Citigroup Inc Heron Therapeutics, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 85,983 shares of HRTX stock, worth $133,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,983

Previous 50,480 70.33%

Holding current value

$133,273

Previous $176,000 2.84%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$1.73 - $3.67 $61,420 - $130,296	35,503 Added 70.33%	85,983 $171,000
Q2 2024 Aug 12, 2024	BUY	$2.32 - $3.86 $76,599 - $127,445	33,017 Added 189.07%	50,480 $176,000
Q1 2024 May 10, 2024	SELL	$1.71 - $3.06 $1,670 - $2,989	-977 Reduced 5.3%	17,463 $48,000
Q4 2023 Feb 09, 2024	BUY	$0.54 - $1.82 $9,844 - $33,178	18,230 Added 8680.95%	18,440 $31,000
Q3 2023 Nov 09, 2023	SELL	$0.97 - $1.8 $29,715 - $55,143	-30,635 Reduced 99.32%	210 $0
Q2 2023 Aug 10, 2023	BUY	$1.11 - $2.88 $22,657 - $58,786	20,412 Added 195.65%	30,845 $35,000
Q1 2023 May 11, 2023	SELL	$1.51 - $3.25 $848 - $1,826	-562 Reduced 5.11%	10,433 $15,000
Q4 2022 Feb 09, 2023	SELL	$2.25 - $4.67 $1.23 Million - $2.55 Million	-546,097 Reduced 98.03%	10,995 $27,000
Q3 2022 Nov 10, 2022	SELL	$2.66 - $5.37 $549,085 - $1.11 Million	-206,423 Reduced 27.04%	557,092 $2.35 Million
Q2 2022 Aug 10, 2022	BUY	$2.3 - $6.29 $1.41 Million - $3.86 Million	612,908 Added 406.96%	763,515 $2.13 Million
Q1 2022 May 12, 2022	SELL	$4.63 - $9.94 $1.34 Million - $2.88 Million	-290,077 Reduced 65.82%	150,607 $861,000
Q4 2021 Feb 10, 2022	BUY	$8.35 - $12.6 $2.04 Million - $3.08 Million	244,403 Added 124.52%	440,684 $4.02 Million
Q3 2021 Nov 10, 2021	BUY	$10.13 - $15.0 $1.99 Million - $2.94 Million	196,281 New	196,281 $2.1 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account